Bridges Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-244,382
Closed -$24.3M 419
2019
Q3
$24.3M Sell
244,382
-115,454
-32% -$11M 0.93% 33
2019
Q2
$33.3M Sell
359,836
-125,681
-26% -$11.9M 1.27% 22
2019
Q1
$45.8M Sell
485,517
-70,268
-13% -$6.15M 1.87% 16
2018
Q4
$35.6M Buy
555,785
+236,174
+74% +$17.4M 1.67% 16
2018
Q3
$28.6M Buy
319,611
+38,406
+14% +$3.39M 1.41% 16
2018
Q2
$22.3M Buy
281,205
+14,683
+6% +$1.22M 1% 25
2018
Q1
$23.8M Buy
266,522
+66,752
+33% +$6.41M 1.09% 24
2017
Q4
$20.8M Buy
199,770
+10,043
+5% +$1.13M 1.68% 13
2017
Q3
$27.7M Buy
189,727
+54,902
+41% +$7.48M 2.62% 12
2017
Q2
$17.5M Buy
134,825
+180
+0.1% +$22.1K 2.35% 11
2017
Q1
$16.8M Buy
134,645
+3,622
+3% +$433K 2.31% 11
2016
Q4
$15.2M Buy
131,023
+3,473
+3% +$387K 2.15% 12
2016
Q3
$13.3M Sell
127,550
-695
-0.5% -$75.2K 2.22% 12
2016
Q2
$12.6M Buy
128,245
+5,020
+4% +$519K 2.19% 11
2016
Q1
$12.3M Buy
123,225
+4,541
+4% +$468K 2.24% 11
2015
Q4
$14.2M Buy
118,684
+6,173
+5% +$714K 2.54% 10
2015
Q3
$13M Hold
112,511
2.26% 11
2015
Q2
$13M Buy
112,511
+7,430
+7% +$849K 2.26% 11
2015
Q1
$12.1M Buy
105,081
+2,995
+3% +$358K 2.12% 11
2014
Q4
$11.4M Buy
102,086
+4,010
+4% +$423K 2.02% 11
2014
Q3
$9.3M Buy
98,076
+800
+0.8% +$72.2K 1.74% 12
2014
Q2
$8.35M Buy
97,276
+9,816
+11% +$746K 1.59% 14
2014
Q1
$6.11M Buy
87,460
+9,930
+13% +$786K 1.27% 22
2013
Q4
$6.55M Buy
77,530
+350
+0.5% +$27.7K 1.48% 16
2013
Q3
$5.95M Buy
77,180
+2,900
+4% +$203K 1.48% 16
2013
Q2
$4.34M Buy
+74,280
New +$4.47M 1.15% 23

Other funds holding CELG

Bridges Investment Management's CELG Position: Q4 2019 in Review

Bridges Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 244,382 shares — an estimated $24.3M sold.

Bridges Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $45.8M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bridges Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bridges Investment Management sold 244,382 Celgene Corp shares in Q4 2019, an estimated $24.3M.
  • Bridges Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bridges Investment Management's Celgene Corp position peaked at $45.8M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bridges Investment Management's 13F filing for Q4 2019, filed 18 Feb 2020.